Literature DB >> 23822928

Aortic stiffness and cardiovascular risk in type 2 diabetes.

Abdellah Salah Mansour1, Alexandra Yannoutsos, Nilla Majahalme, Davide Agnoletti, Michel E Safar, Said Ouerdane, Jacques Blacher.   

Abstract

OBJECTIVE: Damage to large arteries is a major contributor to high cardiovascular morbi-mortality in type 2 diabetic patients. Pulse wave velocity (PWV), depending on both structural and functional characteristics of the arterial wall, has poorly been ascertained in its ability to be a marker of cardiovascular risk in diabetic patients. In order to determine the factors influencing aortic stiffness, and the potential predictor role of this measurement, a cross-sectional study on a cohort of 618 type 2 diabetic patients with or without cardiovascular events was conducted.
METHODS: Aortic PWV (estimated by carotid-femoral PWV measurement) was determined using an automatic device and cardiovascular risk was determined, using Framingham equation (10-year absolute cardiovascular disease risk), in individuals without previous cardiovascular events. Multilinear regression analysis was performed to assess relationships between aortic PWV, population characteristics and the presence of cardiovascular disease. Multivariate models (with and without PWV) were compared to determine whether aortic PWV improves explicative model of presence of cardiovascular disease.
RESULTS: Increased aortic PWV was strongly associated with presence of coronary, cerebral and peripheral vascular diseases. Increased aortic PWV was independently associated with previous cardiovascular events and improved the explicative model of presence of cardiovascular disease above the known cardiovascular risk factors.
CONCLUSION: This study provides evidence that aortic PWV is a forceful independent marker of cardiovascular disease in diabetic patients, as it has already been demonstrated in hypertensive individuals. Prospective trials are needed to assess the improvement in cardiovascular risk prediction for widespread use of aortic PWV in diabetic patients.

Entities:  

Mesh:

Year:  2013        PMID: 23822928     DOI: 10.1097/HJH.0b013e3283613074

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  20 in total

1.  Association between whole blood viscosity and arterial stiffness in patients with type 2 diabetes mellitus.

Authors:  Ying Li; Xiu-xia Tian; Tiemin Liu; Rui-tao Wang
Journal:  Endocrine       Date:  2014-10-14       Impact factor: 3.633

2.  Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus.

Authors:  D Agnoletti; A S Mansour; Y Zhang; A D Protogerou; S Ouerdane; J Blacher; M E Safar
Journal:  J Hum Hypertens       Date:  2016-09-08       Impact factor: 3.012

Review 3.  Arterial stiffness as a risk factor for clinical hypertension.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2017-10-12       Impact factor: 32.419

4.  Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Authors:  Philip M Carlucci; Monica M Purmalek; Amit K Dey; Yenealem Temesgen-Oyelakin; Simantini Sakhardande; Aditya A Joshi; Joseph B Lerman; Alice Fike; Michael Davis; Jonathan H Chung; Martin P Playford; Mohammad Naqi; Pragnesh Mistry; Gustavo Gutierrez-Cruz; Stefania Dell'Orso; Faiza Naz; Taufiq Salahuddin; Balaji Natarajan; Zerai Manna; Wanxia L Tsai; Sarthak Gupta; Peter Grayson; Heather Teague; Marcus Y Chen; Hong-Wei Sun; Sarfaraz Hasni; Nehal N Mehta; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-04-19

5.  Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study.

Authors:  Tapan Mehta; Eugene Nuccio; Kim McFann; Magdalena Madero; Mark J Sarnak; Diana Jalal
Journal:  Am J Hypertens       Date:  2014-12-31       Impact factor: 2.689

6.  Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes.

Authors:  Ryotaro Bouchi; Isao Minami; Norihiko Ohara; Yujiro Nakano; Rie Nishitani; Masanori Murakami; Takato Takeuchi; Momoko Akihisa; Tatsuya Fukuda; Masamichi Fujita; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  BMJ Open Diabetes Res Care       Date:  2015-03-10

Review 7.  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.

Authors:  Dimitrios Patoulias; Christodoulos Papadopoulos; Konstantinos Stavropoulos; Ioanna Zografou; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-14       Impact factor: 3.738

8.  Associations between Type 2 Diabetes Mellitus and Arterial Stiffness: A Prospective Analysis Based on the Maine-Syracuse Study.

Authors:  Merrill F Elias; Georgina E Crichton; Peter J Dearborn; Michael A Robbins; Walter P Abhayaratna
Journal:  Pulse (Basel)       Date:  2017-08-26

9.  Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function.

Authors:  Lynda Cheddani; Jean Philippe Haymann; Sophie Liabeuf; Nahid Tabibzadeh; Jean-Jacques Boffa; Emmanuel Letavernier; Marie Essig; Tilman B Drüeke; Michel Delahousse; Ziad A Massy
Journal:  Clin Kidney J       Date:  2020-09-03

10.  The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.

Authors:  David Zi Cherney; Bruce A Perkins; Nima Soleymanlou; Ronnie Har; Nora Fagan; Odd Erik Johansen; Hans-Juergen Woerle; Maximilian von Eynatten; Uli C Broedl
Journal:  Cardiovasc Diabetol       Date:  2014-01-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.